Breathe Well Live Well
Condition: Asthma
Interventions: Drug: Fp MDPI; Drug: FS MDPI; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified November 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Lung Disease News |
Dedicated Asthma Program Can Improve Treatment in Kids, Teens Compared to Routine Healthcare Visits
Lung Disease News Researchers from the Children's Hospital at Montefiore (CHAM) reported that a groundbreaking primary care-based program for asthma patients, called Pediatric Preventive Asthma Care Program, could improve the identification of mistreated asthma among … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: MK-0887A 100/10 mcg; Drug: MK-0887 100 mcg; Drug: Albuterol/Salbutamol; Drug: Prednisone/Prednisolone
Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting – verified April 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Other: Comparative epidemiological survey
Sponsor: Hospital St. Joseph, Marseille, France
Recruiting – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: QMF149; Drug: QMF149; Drug: MF 400; Drug: MF 400; Drug: salmeterol /fluticasone
Sponsor: Novartis Pharmaceuticals
Not yet recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Treatment A: Fp MDPI; Drug: Treatment B: FS MDPI; Drug: Treatment C Flovent; Drug: Treatment D: Advair
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: QGE031; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting – verified January 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh; Drug: Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh; Drug: Symbicort Turbuhaler 320/9 ug/inhalation 4 inh; Drug: Symbicort Turbuhaler 320/9 ug/inhalation 1inh; Drug: Placebo Symbicort Turbuhaler 320/9 ug/inhalation 4 inh; Drug: Placebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh; Drug: Placebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh; Drug: Placebo Symbicort Turbuhaler 320/9 ug/inhalation 1 inh
Sponsor: Orion Corporation, Orion Pharma
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Healthy
Interventions: Drug: Tiotropium/Salmeterol; Drug: Serevent® Diskus®; Drug: Spiriva®
Sponsor: Boehringer Ingelheim
Completed – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Berodual® Respimat®, low dose; Drug: Berodual® Respimat®, high dose; Drug: Berodual® MDI
Sponsor: Boehringer Ingelheim
Completed – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days